News Posts List
What is Seattle Care Alliance?
06/30/2012
Our goal, every day, is to turn cancer patients into cancer survivors.
FDA grants priority review to Bayer's regorafenib
06/30/2012
Bayer, the inventor of Aspirin which also makes plastics and pesticides, is also testing regorafenib against a number of tumor types including kidney cancer.
Denise Richards Meets With Cancer Survivors
06/29/2012
Hollywood star puts spotlight on Kidney Cancer Association. Denise Richards, who starred as Dr. Christmas Jones in the James Bond classic, The World is Not Enough, recently hosted a group of kidney cancer survivors and family members at a private luncheon in Hollywood.
Kidney Cancer Association's Survivors Project
06/27/2012
People are living longer with kidney cancer than ever before.
Chromophobe renal cell carcinoma
06/26/2012
The following manuscript will endeavor to provide an overview of this uncommon entity including pathology, epidemiology, genetics, clinical aspects, and current and future treatment options.
Why Biomarker Discovery Is Hard
06/26/2012
What scientists have characterized as the deluge of information that has emerged from genome-scale studies has forced parallel development of new analytical frameworks and tools.
Cost of Medicines to Fall for Thousands of Australians
06/26/2012
Around 45,000 people will benefit from new, cheaper medicines following the Governmentâs approval of eleven new medicines on the Pharmaceutical Benefits Scheme.
Calgary-area cancer ride conquers personal mountains
06/25/2012
It wasnât the greatest weekend to bike more than 200 kilometers, but it was nowhere near the worst thing theyâve been through.
What Motivates Researcher to Make Breakthrough Discoveries?
06/23/2012
âItâs been very rewarding,â said Dr. Bin Tean Teh, the lead researcher in the study. âWhen somebody close to you has (the cancer), obviously the impact is greater. It makes it more personal, more passionate.â
2013: BIO Comes to Chicago
06/21/2012
Governor Patrick Quinn of Illinois visited the BIO International Convention to talk about the biotech sector in his state, built on a solid foundation of commercial, R&D and academic communities.